Emmanuel Antonarakis

Emmanuel Antonarakis is a Professor in the Department of Medicine at the University of Minnesota, School of Medicine, specializing in Hematology, Oncology, and Transplant Genetics. His research is centered on the mechanisms of cancer, particularly in the context of prostate cancer and its progression to castration-resistant forms.

• Institution: University of Minnesota
• School: School of Medicine
• Department: Department of Medicine
• Role: Professor and Principal Investigator

His research interests include prostate cancer biology, androgen receptor signaling, metastatic castration-resistant prostate cancer (mCRPC), liquid biopsy, biomarker discovery, and novel therapeutic strategies such as bipolar androgen therapy and immunotherapy. He is actively involved in translational research, bridging laboratory findings to clinical applications.

The recent articles highlight a strong focus on developing and evaluating new treatments for prostate cancer, including immune-based therapies targeting PSMA, pharmacokinetic studies of novel agents like ACE-232, and biomarker development for radioligand therapy. There is a clear trend toward precision oncology, leveraging proteogenomics, circulating tumor DNA, and AI-designed therapeutics to improve patient outcomes.

Dr. Antonarakis leads multiple significant research projects funded by the Prostate Cancer Foundation, Novartis, US Department of Defense, and biotech companies. These projects focus on cellular plasticity in CRPC, immune cell-mediated eradication of cancer cells, and biomarker development for advanced therapies.

• AI-Designed Mini-Proteins for Immune Eradication of CRPC
• Liquid Biopsy Biomarkers for 177Lu-PSMA Therapy
• Phase 1 Trials of Novel Agents in mCRPC
• Targeting Alternative Polyadenylation in CRPC

He has no listed scientific awards in the provided text, but his extensive publication record and leadership in high-impact clinical trials indicate significant recognition in the field. He collaborates widely with experts in oncology, genetics, and immunology, and his work contributes to UN Sustainable Development Goals related to good health and well-being.